New Approach Methodologies (NAMs) have been around a while but recently they have been getting a lot more visibility thanks to recent FDA and NIH press release announcements and workshops.

The recent commentary on “Dual use of artificial-intelligence-powered drug discovery” has garnered some visibility over the last week in the popular press.